HomeNDC LookupIngredientsSennosides › 57237-0301-24
Senna Syrup Sennosides 8.8 mg/5mL Liquid, 237 mL — NDC 57237-0301-24 package photo

Senna Syrup Sennosides 8.8 mg/5mL Liquid, 237 mL

by Rising Pharma Holdings, Inc. · 237 mL in 1 BOTTLE (57237-301-24)
NDC 57237-0301-24
🏷️ FDA NDC (as labeled) 57237-301-24 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 57237-301-24
Product NDC 57237-301
11-digit billing NDC 57237030124
NCPDP billing unit ML — per mL (volume)
RxCUI 702311
UNII 3FYP5M0IJX
Application # M007.60
SPL Set ID dc636b83-6eca-412e-bac5-0c736b371ca7
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-09-27
Route ORAL
Dosage form LIQUID
Substance SENNOSIDES
GPI-14 46200060201220
GCN Seq No 002922
GCN 08660
HICL code 001289
Ingredient (HICL) Sennosides
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name SENNA 8.8 MG/5 ML SYRUP
FDB brand name Senna
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 57237-301-24 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 57237-0301-24. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerRising Pharma Holdings, Inc.
FDA applicationM007.60 (OTC MONOGRAPH DRUG)
Labeler code57237
First marketedSep 2022
Product typeHuman Otc Drug
Portfolio525 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name SENNA 8.8 MG/5 ML SYRUP Ingredient Sennosides
📖 What it is MedlinePlus · NLM

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
  • How long does it take for senna to work?
  • Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
  • Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
📖 Read our full Senna guide →
3
Nutrient depletion considerations

Sennosides (OTC drug) may be associated with lower levels of 3 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color brown
FlavorChocolate
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.038 $8.89 / 237 ml
Medicaid paysCMS SDUD · 12 mo $0.0583 $13.82 / 237 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2023 Dec 2025 Apr 2026 Aug 2026 $0.042 $0.035
▲ Up 7% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senna Liquid 8.8 mg/5mL 00536-1266-59 RUGBY 237 ml $0.038 Availability likely
Senna 8.8 mg/5mL 39328-0020-08 Patrin 237 ml $0.038 Availability likely
Senna Syrup 8.8 mg/5mL 54859-0808-08 Llorens 237 ml $0.038 Availability likely
Senna Syrup 8.8 mg/5mLthis 57237-0301-24 Rising 237 ml $0.038 Availability likely
Senna Syrup 8.8 mg/5mL 58657-0518-08 Method 237 ml $0.038 Availability likely
Senna 8.8 mg/5mL 82568-0024-08 AARNA 237 ml $0.038 Availability likely
Senna 8.8 mg/5mL 00121-4967-40 PAI 10 cups FDA listed
Senna 8.8 mg/5mL 00536-1483-59 Rugby 237 ml FDA listed
Senna 8.8 mg/5mL 00904-7528-94 Major 10 cups FDA listed
OneLAX SENNA 417.12 mg/237mL 17856-1127-01 ATLANTIC 120 syringes FDA listed
OneLAX SENNA 417.12 mg/237mL 17856-8127-02 Atlantic 50 cups FDA listed
Senna UD 8.8 mg/5mL 39328-0120-50 Patrin 10 cups FDA listed
Senna UD 26.4 mg/15mL 39328-0220-50 Patrin 10 cups FDA listed
Senna Syrup 8.8 mg/5mL 48433-0219-40 Safecor 40 cups FDA listed
Senna Syrup 8.8 mg/5mL 50268-0731-24 AVPAK 24 cups FDA listed
Senna Syrup 8.8 mg/5mL 57237-0310-54 Rising 40 cups FDA listed
GeriCare Senna Syrup 8.8 mg/5mL 57896-0472-08 Geri-Care 237 ml FDA listed
Senna 8.8 mg/5mL 60687-0851-77 American 10 cups FDA listed
Senna Syrup 8.8 mg/5mL 63629-9268-01 Bryant 237 ml FDA listed
SENNA Syrup 8.8 mg/5mL 66424-0562-08 SDA 236 ml FDA listed
Senna 417.12 mg/237mL 68094-0049-62 Precision 10 cups FDA listed
Senna 8.8 mg/5mL 69618-0069-58 Reliable 237 ml FDA listed
OneLAX SENNA 417.12 mg/237mL 71399-0027-08 Akron 237 ml FDA listed
Senna Syrup 8.8 mg/5mL 72090-0022-01 Pioneer 237 ml FDA listed
Senna Syrup 8.8 mg/5mL 72162-1672-02 Bryant 237 ml FDA listed
Senna Syrup 8.8 mg/5mL 73564-0812-08 Aldama 1 bottle FDA listed
Senna Syrup 8.8 mg/5mL 81033-0120-50 Kesin 50 cups FDA listed
Senna Syrup 8.8 mg/5mL 84415-0021-01 Everpharm 100 cups FDA listed
Senna Liquid 8.8 mg/5mL 84447-0120-01 Belleview 200000 ml FDA listed
Curewell Senna Syrup 8.8 mg/5mL 85111-0452-08 RMT 1 bottle FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Sep 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 57237-0301-24, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
27.1K
Units reimbursed last 4 qtrs
6M
Gross reimbursed last 4 qtrs
$347.7K
Avg / prescription
$12.81
Avg / unit
$0.0583
Latest quarter Q1 2026
6.5KRx
Medicaid pays / mL
$0.0583
gross reimbursed
vs
NADAC / mL
$0.0375
acquisition cost
=
Spread
+$0.0208
+55% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
44% FFS 56% MCO
Fee-for-service · 11,880 Rx Managed care · 15,263 Rx
State Medicaid map
Alaska: no data reported AK Maine: 84,143 units · 6,032 per 100k residents ME Washington: 101,126 units · 1,294 per 100k residents WA Idaho: 26,443 units · 1,346 per 100k residents ID Montana: 7,047 units · 623 per 100k residents MT North Dakota: no data reported ND Minnesota: 347,942 units · 6,065 per 100k residents MN Wisconsin: 349,709 units · 5,917 per 100k residents WI Michigan: 303,800 units · 3,027 per 100k residents MI New York: 453,863 units · 2,319 per 100k residents NY Vermont: 23,494 units · 3,631 per 100k residents VT New Hampshire: 24,200 units · 1,726 per 100k residents NH Oregon: 122,350 units · 2,890 per 100k residents OR Nevada: 12,661 units · 396 per 100k residents NV Wyoming: 5,824 units · 997 per 100k residents WY South Dakota: no data reported SD Iowa: 93,581 units · 2,918 per 100k residents IA Illinois: 208,539 units · 1,662 per 100k residents IL Indiana: 168,900 units · 2,461 per 100k residents IN Ohio: 660,996 units · 5,609 per 100k residents OH Pennsylvania: 761,042 units · 5,872 per 100k residents PA New Jersey: 197,516 units · 2,126 per 100k residents NJ Massachusetts: 221,163 units · 3,159 per 100k residents MA California: no data reported CA Utah: 23,195 units · 679 per 100k residents UT Colorado: 5,564 units · 94.7 per 100k residents CO Nebraska: 140,512 units · 7,104 per 100k residents NE Missouri: 186,204 units · 3,005 per 100k residents MO Kentucky: 273,888 units · 6,051 per 100k residents KY West Virginia: no data reported WV Virginia: 165,879 units · 1,903 per 100k residents VA Maryland: 67,617 units · 1,094 per 100k residents MD Connecticut: 117,514 units · 3,249 per 100k residents CT Rhode Island: 46,404 units · 4,238 per 100k residents RI Arizona: 148,399 units · 1,997 per 100k residents AZ New Mexico: no data reported NM Kansas: 98,250 units · 3,342 per 100k residents KS Arkansas: no data reported AR Tennessee: 351,691 units · 4,935 per 100k residents TN North Carolina: no data reported NC South Carolina: 107,484 units · 2,000 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: 49,098 units · 7,231 per 100k residents DC Hawaii: no data reported HI Texas: 7,635 units · 25.0 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
25.07,231
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 D.C. 7,231 /100k
2 Nebraska 7,104 /100k
3 Minnesota 6,065 /100k
4 Kentucky 6,051 /100k
5 Maine 6,032 /100k
6 Wisconsin 5,917 /100k
7 Pennsylvania 5,872 /100k
8 Ohio 5,609 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Senna Syrup (this brand).

Top reported reactions

Pyrexia701
Pain651
Constipation646
Fatigue642
Dyspnoea613
Headache611
Asthma563

Age at onset

Infant4
Child24
Adolescent26
Adult611
Elderly1,020

Reporter sex

7,208 reports
Male · 48%
Female · 52%
Unknown · 0%

Serious outcomes

Hospitalization4,040
Life-threatening917
Disabling213
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 926 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
57237-0301-24 You're viewing this 237 mL in 1 BOTTLE (57237-301-24) 2022-09-27 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 14 words

Uses relieves occasional constipation (irregularity) generally causes bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 62 words

Directions shake well before using Do not exceed recommended dose Age Starting Dose Maximum Dose adults and children 12 years and older 2 to 3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor 3 teaspoonfuls in the morning and 3 teaspoonfuls at bedtime Under 12 years of age ask a doctor ask a doctor

⚠️ Warnings 68 words

Warnings Do not use laxative products for longer than 1 week unless directed by a doctor. Ask a doctor before use if you have stomach pain, nausea or vomitting noticed a change in bowel habits that lasts over two weeks. Stope use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use of laxative. These may indicate a serious condition.

🤰 Pregnancy 10 words

If pregnant or breast-feeding, ask a health professional before use.

📦 Storage and Handling 29 words

Other information store at room temperature 15° to 25° C (59° to 77° F) TAMPER-EVIDENT: Do not use if foil seal over bottle opening is torn, broken, or missing.

🧪 Active Ingredient 13 words

Senna Syrup Active ingredient (in each 5 mL teaspoonful) Sennosides - 8.8 mg

🧪 Inactive Ingredients 14 words

Inactive ingredients: artificial and natural chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water, sucrose.

🎯 Purpose 2 words

Purpose Laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.